4-amino-3-phenylbutyric acid has been researched along with mebikar in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kresiun, VI | 1 |
| Anisimova, TI; Bondarchuk, IL; Chutko, LS; Iakovenko, EA; Nikishena, IS; Sergeev, AV; Surushkina, SI | 1 |
1 trial(s) available for 4-amino-3-phenylbutyric acid and mebikar
| Article | Year |
|---|---|
[Asthenic disorders in children and their differentiated treatment].
Topics: Adolescent; Anti-Anxiety Agents; Anxiety; Asthenia; Biureas; Fatigue; Female; GABA Agonists; gamma-Aminobutyric Acid; Humans; Male; Neurasthenia; Psychiatric Status Rating Scales; Self-Assessment; Surveys and Questionnaires; Treatment Outcome | 2014 |
1 other study(ies) available for 4-amino-3-phenylbutyric acid and mebikar
| Article | Year |
|---|---|
[Disorders in brain levels of macroergic substances during chronic stress and their correction by psychotropic agents].
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Biureas; Brain; Chlordiazepoxide; gamma-Aminobutyric Acid; Humans; Lithium; Male; Meprobamate; Rats; Stress, Psychological; Tranquilizing Agents | 1983 |